Article Information
History
- March 15, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ziyang Huang1,2,†,
- Jingyuan Luo3,4,5,†,
- Haoran Li1,
- Xingye Cheng1,
- Jialing Zhang3,4,5,
- Hiu To Tang3,4,
- Hoi Ki Wong3,4,
- Chun Hoi Cheung3,4,
- Zhaoxiang Bian3,4,5,*,
- Aiping Lyu2,3,6,* and
- Liang Tian1,2,7,8,*
- 1Department of Physics, Hong Kong Baptist University, Hong Kong, China
- 2Institute of Systems Medicine and Health Sciences, Hong Kong Baptist University, Hong Kong, China
- 3School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
- 4Vincent V.C Woo Chinese Medicine Clinical Research Institute, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
- 5Centre for Chinese Herbal Medicine Drug Development, Hong Kong Baptist University, Hong Kong SAR, China
- 6Centre for Cancer & Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
- 7Institute of Computational and Theoretical Studies, Hong Kong Baptist University, Hong Kong, China
- 8State Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University, Hong Kong, China
- ↵*Corresponding authors: Liang Tian: SCT904, Cha Chi-ming Science Tower, Ho Sin Hang Campus, Hong Kong Baptist University, 224 Waterloo Road, Kowloon, Hong Kong SAR, China. Email address: liangtian{at}hkbu.edu.hk; Aiping Lyu: Jockey Club School of Chinese Medicine Building, 7 Baptist University Road, Kowloon, Hong Kong SAR, China. Email address: aipinglu{at}hkbu.edu.hk; Zhaoxiang Bian: Hong Kong Baptist University, 3/F, Jockey Club School of Chinese Medicine Building, 7 Baptist University Road, Kowloon, Hong Kong SAR, China. Email address: bzxiang{at}hkbu.edu.hk)
↵† These authors contributed equally to this article
Posted March 15, 2024.
Incidence, risk factors, and clinical symptom profile of reinfection during Omicron-dominated COVID-19 outbreak in Hong Kong: A retrospective cohort study
